Clinical Trial Update: SHR-1701 Combined with SHR2554 and BP102 for MCRC [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study combining SHR-1701, SHR2554, and BP102 in metastatic colorectal cancer, sponsored by Fudan University; the trial is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BP102
• SHR-1701
• SHR2554

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING